Curriculum and Presentations

HIVLN sessions are held every second and fourth Thursday of each month from 12 noon – 1 PM Pacific Time. Sessions are divided into 2 main sections:

short didactic and
case discussions.

Leading HIV experts throughout California present HIV-related topics to support and expand participating health care providers’ HIV knowledge base and clinical skills. Case discussions include relevant teaching cases from HIV experts and cases introduced by participating health care providers who desire consultation.

For Our Participants

Submit a Case for Discussion

Download the case form (MS Word file) and
complete and submit the case form to Moira Mar-Tang, MPH, CHES at mmartang@ucsd.edu.

Test Your Computer Connection

In preparation for conferencing with us, please

review Tips on Participating on HIVLN and
run the connection test. This test will take less than two minutes.

Before the day of the event verify that the connection test is successful: Your computer may lack the appropriate Adobe Connect plug-ins to participate in sessions. If you are not able to establish a connection, please contact your IT liaison or the HIVLN Program Coordinator.

2013 Presentations

5/9/13: Conference on Retroviruses and Opportunistic Infections (CROI) Update 2013

Coming soon…

4/25/13: Approach to Common Complaints among HIV+ Patients: Headaches & Fever

Session Adobe Connect Recording
Slides Approach to Common Complaints in HIV+ Patients Headache and Fever
Resources

Switching from Atripla to Complera Safe and Effective in 12 Week Study

HRSA Guide for HIV/AIDS Clinical Care: Fever

HRSA Guide for HIV/AIDS Clinical Care: Headache

4/11/13: Opportunistic Infections: Prophylaxis

Session Adobe Connect Recording
Slides
Opportunistic Infection Prophylaxis
Resources

Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-infected Adults and Adolescents MMWR Report

“Pneumocystis Pneumonia” by Charles F. Thomas, Jr., MD, and Andrew H. Limper, MD

“Prophylaxis Against Opportunistic Infections in Patients with HIV Infection” by Joseph A. Kovacs, MD, and Henry Masur, MD

“Blood (1-3)-b-D-Glucan as a Diagnostic Test for HIV-Related Pneumocystis jirovecii Pneumonia”

3/28/2013: HIV Testing

SessionAdobe Connect Recording
Slides HIV Testing
Resources
"HIV Testing in Primary Care: The Reachable Moment" Training Video

3/14/2013: HIV/HCV Co-infection

Session Adobe Connect Recording
Slides How to Cure HIV: from Berlin to Mississippi
Resources
Long-Term Control of HIV by CCR5 Delta32/ Delta32 Stem-Cell Transplantation

2/28/13: The Anti-Retroviral Story: Simplifying a Complex Saga for our Patients

Session Recording coming soon
Resources

ARV Story LifeCycle Worksheet

Pill Chart

Following an HIV Treatment Regimen

1/24/2013: HIV/HCV Co-infection

Session Adobe Connect Recording
Slides
HIV/HCV Co-infection
Resources

Provisional Guidance on the Use of Hepatitis C Virus Protease Inhibitors for Treatment of Hepatitis C in HIV-infected Persons

Initial Evaluation of New Newly Diagnosed HCV Patient

Drug Interactions with HCV NS3/4A Protease Inhibitors and HIV Medications: A Quick Guide for Clinicians – Updated September 2012

1/10/2013: STD Screening & Treatment: Syphilis

More information to come.
Session Adobe Connect Recording
Slides
-Christian B. Ramers, MD, MPH, STD Screening & Management: Syphilis
Resources
- California STD Treatment Guidelines Table for Adults & Adolescents 2010
- Primary Care Guidelines for the Management of Persons Infected with HIV: 2009 Update by the HIV Medicine Association of the IDSA
- MMWR: Sexually Transmitted Diseases Treatment Guidelines, 2010
- Adult & Adolescent Opportunistic Infection, Prevention & Treatment

2012 Presentations

9/27/2012: Sex PEP: “We had sex and I think that I was exposed to HIV” … Now what do you do?

Session
- View the Adobe Connect recording
Slides
- Jacqueline Tulsky, MD, I Had Sex with Someone and Now I Wonder if I Could Get HIV
Resources
- MMWR, Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States

8/30/2012: Update: 2012 HIV Treatment Recommendations

Session
- View the Adobe Connect recording
Slides
- Daniel Lee, MD, Update: 2012 HIV Treatment Guidelines and Craig Ballard, PharmD, Resistance Testing
Resources
- Thompson, Antiretroviral Treatment of Adult HIV Infection (2012)

3/22/2012: HIV epidemiology & testing

Session
- View the Adobe Connect recording
Slides
- Sophy Wong, MD, HIV Epidemiology and Testing and Daniel Lee, MD, Interpreting HIV Antibody Tests
Resources
- FDA, Drug Interactions with Statins (2012)

2/23/2012: Management of Newly Dx HIV Patient, Part III: Initiate HAART or not?

Session
- View the Adobe Connect recording
Slides
-Greg Melcher, MD, Management of a Newly Diagnosed Patient: Start HAART or Not?

2/9/2012: Management of Newly Dx HIV Patient, Part II: Labs, test, immunizations, preventive screens

Slides
- Daniel Lee, MD, Management of a Newly Diagnosed Patient: Initial Labs, Other Tests, and Immunizations

1/26/2012: Orientation and Management of Newly Dx HIV Patient, Part I: H&P

Slides
- Jacqueline Tulsky, MD, Management of a Newly Diagnosed HIV+ Patient: H & P

HIV Learning Network

CME accreditation

The University of California, San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of California, San Diego School of Medicine designates this educational activity for a maximum of one credit per hour AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation.